通过来自白花粉的低分子量成分调节支气管上皮屏障完整性
Srinidhi Sudharson1,2, Tanja Kalic1,2, Julia Eckl-Dorna3
1Department of Dermatology, University Hospital Sankt Poelten, Karl Landsteiner University of Health Sciences, 3100 Sankt Poelten, Austria.
International journal of molecular sciences
|July 13, 2024
概括
白花粉 (BP) 的低分子量成分 (LMC) 增强了上皮屏障的功能和修复. 此外,BP LMC还调节炎性细胞因子的释放,影响呼吸道上皮反应.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 花粉含有低分子量成分 (LMC) 低于3kDa,与过敏反应有关.
- 树花粉 (BP) 衍生的LMC在支气管上皮细胞相互作用中的特定作用仍未得到充分研究.
研究的目的:
- 研究BP衍生的LMC如何影响支气管上皮质屏障的完整性和功能.
- 分析BP LMC对上皮细胞细胞因子释放的影响.
主要方法:
- 利用了16HBE14o-人类支气管上皮细胞系.
- 通过跨皮电阻和xCELLigence系统评估屏障完整性.
- 使用多重免疫试验测量极化细胞因子释放.
主要成果:
- BP LMC显著增强了上皮膜屏障的完整性.
- BP LMC促进了帕帕因诱导的上皮屏障损伤的修复.
- 减少CCL5和TNF-α的顶部释放;观察到基底侧IL-6释放的增加.
结论:
- 由BP衍生的LMC调节支气管上皮细胞的物理性质和屏障反应.
- LMC在调节气道上皮质免疫功能方面发挥着作用.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
397
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
397
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


